Follow the Bio Essence Corp stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €12.8m. The latest transaction was filed on 18 November 2024 (Cession). Among the most active insiders: Yan Yin. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€5m
2 ops.
Buy Volume
€1m
4 ops.
Sell Volume
30Σ signal
Buys €5m€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,196 of 27,989 companies
72.6
score / 100
Value
66
Quality
80
FCF yld12%
Earn yld7.1%
EV/EBITDA15.8x
ROE·
Gross mgn75%
Net mgn47%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5,000,000 shares@ US$0.5040.6% of flowCommon StockSEC:0001213900-24-049108:0
Canonical exit: 4 Sept 2023 (T+90)
6 of 6 declarations
About Bio Essence Corp
Bio Essence Corp is a company listed on the XNAS market, specializing in the development of skincare and wellness products. It focuses on using natural ingredients for its formulations.